tirzepatide цена българия 5/10 mg — двоен GIP/GLP-1 (Mounjaro) Mounjaro 2,5 mg/доза KwikPen инжекционен

The late responder finding Perhaps the most important finding for someone reading this article: 90 percent of participants who had lost less than 5 percent of their body weight by week 12 ("late responders") went on to achieve clinically meaningful weight loss by week 72

Patients are evaluated individually to ensure proper dosage and medical safety, giving them access to breakthrough therapies without the logistical barriers of traditional clinics

These combined effects make Tirzepatide particularly effective in lowering blood glucose levels and promoting weight reduction in individuals with type 2 diabetes

Certain individuals should avoid tirzepatide